article · BMC Research Notes
OBJECTIVE: Poultry farm environments are recognized as reservoirs of antimicrobial-resistant bacteria with implications for One Health. Klebsiella pneumoniae, a clinically important opportunistic pathogen, has shown rising resistance to third-generation cephalosporins, including cefotaxime. However, data on cefotaxime-resistant K. pneumoniae (CRKP) in poultry environments in Uganda remain limited. This study determined the proportion and characterized CRKP isolated from chicken farm litter in central Uganda. A retrospective study was conducted using 98 archived environmental litter samples collected from 20 commercial broiler farms in Wakiso District, Uganda. Selective culture and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) were used to identify CRKP. Antimicrobial susceptibility testing was performed using the disk diffusion method. Phenotypic assays assessed virulence-associated traits, and PCR was used to detect the ESBL-associated blaCTX-M-15 gene. RESULT: CRKP was detected in 32.7% (32/98) of samples. All isolates were multidrug resistant (MDR), with universal resistance to tetracycline, trimethoprim-sulfamethoxazole, and ampicillin, while no resistance to imipenem was observed. Biofilm formation and hyper mucoviscosity were detected in 21.9% and 18.8% of isolates, respectively. Although all isolates expressed an ESBL phenotype, blaCTX-M-15 was detected in only 18.8%. Poultry environments are reservoirs of MDR-CRKP, revealing the need for strengthened antimicrobial stewardship and environmental AMR surveillance.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s13104-026-07842-2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.